Literature DB >> 30998101

Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML.

Evgenii Shumilov1, Johanna Flach2, Raphael Joncourt3, Naomi Porret3, Gertrud Wiedemann3, Urban Novak4, Eva Gfeller3,5, Barbara Jeker4, Ursula Amstutz5, Thomas Pabst4, Ulrike Bacher3,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30998101     DOI： 10.1080/10428194.2019.1585838

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  Experiences with Next-Generation Sequencing in Relapsed Acute Myeloid Leukemia: A Patient Case Series.

Authors:  Johanna Flach; Evgenii Shumilov; Naomi Porret; Inna Shakhanova; Myriam Legros; Marie-Noëlle Kronig; Raphael Joncourt; Ulrike Bacher; Thomas Pabst
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.